NUS
Nu Skin Enterprises, Inc.
Household & Personal Products
Market Cap$345M
5Y Perf.-81.1%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
NUS vs EL
Revenue, margins, valuation, and 5-year total return — side by side.
EL
The Estée Lauder Companies Inc.
Household & Personal Products
Market Cap$30.80B
5Y Perf.-56.8%
NUS vs EL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | NUS | EL |
|---|---|---|
| Industry | Household & Personal Products | Household & Personal Products |
| Market Cap | $345M | $30.80B |
| Revenue (TTM) | $1.49B | $14.84B |
| Net Income (TTM) | $160M | $-248M |
| Gross Margin | 69.4% | 74.7% |
| Operating Margin | 4.4% | 6.8% |
| Forward P/E | 7.0x | 38.4x |
| Total Debt | $364M | $9.44B |
| Cash & Equiv. | $239M | $2.92B |
NUS vs EL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
NUS
EL
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Nu Skin Enterprises… (NUS) | 100 | 18.9 | -81.1% |
| The Estée Lauder Co… (EL) | 100 | 43.2 | -56.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NUS vs EL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: NUS leads in 5 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. The Estée Lauder Companies Inc. is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
NUS
Nu Skin Enterprises, Inc.
The Income Pick
NUS carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 0 yrs, beta 1.49, yield 3.4%
- Lower volatility, beta 1.49, Low D/E 45.2%, current ratio 2.08x
- Beta 1.49, yield 3.4%, current ratio 2.08x
Best for: income & stability and sleep-well-at-night
EL
The Estée Lauder Companies Inc.
The Growth Play
EL is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth -8.5%, EPS growth -391.7%, 3Y rev CAGR -7.0%
- 10.8% 10Y total return vs NUS's -48.8%
- -8.5% revenue growth vs NUS's -14.3%
Best for: growth exposure and long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | EL | -8.5% revenue growth vs NUS's -14.3% |
| Value | NUS | Lower P/E (7.0x vs 38.4x) |
| Quality / Margins | NUS | 10.8% margin vs EL's -1.7% |
| Stability / Safety | NUS | Beta 1.49 vs EL's 1.73, lower leverage |
| Dividends | NUS | 3.4% yield, vs EL's 2.0% |
| Momentum (1Y) | EL | +46.3% vs NUS's +26.3% |
| Efficiency (ROA) | NUS | 11.3% ROA vs EL's -1.3%, ROIC 7.3% vs 6.5% |
NUS vs EL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
FY 2025
NUS vs EL — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLNUSLAGGINGEL
ELThe Estée Lauder Comp…
2leads
NUSNu Skin Enterprises, …
3leads
6 Total Categories
CATEGORYLEADERvs ELMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
EL4/6
Valuation MetricsMultiples, price ratios, and targets
NUS5/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
NUS9/9
Total Returns1Y, 3Y, 5Y total returns with dividends
EL6/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
NUS1/1
Income & Cash Flow (Last 12 Months)
EL leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
EL is the larger business by revenue, generating $14.8B annually — 10.0x NUS's $1.5B. NUS is the more profitable business, keeping 10.8% of every revenue dollar as net income compared to EL's -1.7%. On growth, EL holds the edge at +4.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | NUSNu Skin Enterpris… | ELThe Estée Lauder … |
|---|---|---|
| RevenueTrailing 12 months | $1.5B | $14.8B |
| EBITDAEarnings before interest/tax | $118M | $1.6B |
| Net IncomeAfter-tax profit | $160M | -$248M |
| Free Cash FlowCash after capex | $46M | $1.3B |
| Gross MarginGross profit ÷ Revenue | +69.4% | +74.7% |
| Operating MarginEBIT ÷ Revenue | +4.4% | +6.8% |
| Net MarginNet income ÷ Revenue | +10.8% | -1.7% |
| FCF MarginFCF ÷ Revenue | +3.1% | +8.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | -16.9% | +4.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +139.7% | -45.5% |
EL leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
NUS leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, NUS's 3.3x EV/EBITDA is more attractive than EL's 20.9x.
| Metric | NUSNu Skin Enterpris… | ELThe Estée Lauder … |
|---|---|---|
| Market CapShares × price | $345M | $30.8B |
| Enterprise ValueMkt cap + debt − cash | $471M | $37.3B |
| Trailing P/EPrice ÷ TTM EPS | 2.21x | -27.08x |
| Forward P/EPrice ÷ next-FY EPS est. | 7.02x | 38.44x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 3.29x | 20.88x |
| Price / SalesMarket cap ÷ Revenue | 0.23x | 2.16x |
| Price / BookPrice ÷ Book value/share | 0.44x | 7.95x |
| Price / FCFMarket cap ÷ FCF | 7.50x | 45.97x |
NUS leads this category, winning 5 of 6 comparable metrics.
Profitability & Efficiency
NUS leads this category, winning 9 of 9 comparable metrics.
Profitability & Efficiency
NUS delivers a 20.4% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $-6 for EL. NUS carries lower financial leverage with a 0.45x debt-to-equity ratio, signaling a more conservative balance sheet compared to EL's 2.44x. On the Piotroski fundamental quality scale (0–9), NUS scores 6/9 vs EL's 4/9, reflecting solid financial health.
| Metric | NUSNu Skin Enterpris… | ELThe Estée Lauder … |
|---|---|---|
| ROE (TTM)Return on equity | +20.4% | -6.3% |
| ROA (TTM)Return on assets | +11.3% | -1.3% |
| ROICReturn on invested capital | +7.3% | +6.5% |
| ROCEReturn on capital employed | +7.9% | +6.3% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 4 |
| Debt / EquityFinancial leverage | 0.45x | 2.44x |
| Net DebtTotal debt minus cash | $126M | $6.5B |
| Cash & Equiv.Liquid assets | $239M | $2.9B |
| Total DebtShort + long-term debt | $364M | $9.4B |
| Interest CoverageEBIT ÷ Interest expense | 15.14x | 1.14x |
NUS leads this category, winning 9 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
EL leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in EL five years ago would be worth $3,170 today (with dividends reinvested), compared to $2,002 for NUS. Over the past 12 months, EL leads with a +46.3% total return vs NUS's +26.3%. The 3-year compound annual growth rate (CAGR) favors EL at -23.7% vs NUS's -38.9% — a key indicator of consistent wealth creation.
| Metric | NUSNu Skin Enterpris… | ELThe Estée Lauder … |
|---|---|---|
| YTD ReturnYear-to-date | -26.9% | -19.8% |
| 1-Year ReturnPast 12 months | +26.3% | +46.3% |
| 3-Year ReturnCumulative with dividends | -77.1% | -55.6% |
| 5-Year ReturnCumulative with dividends | -80.0% | -68.3% |
| 10-Year ReturnCumulative with dividends | -48.8% | +10.8% |
| CAGR (3Y)Annualised 3-year return | -38.9% | -23.7% |
EL leads this category, winning 6 of 6 comparable metrics.
Risk & Volatility
Evenly matched — NUS and EL each lead in 1 of 2 comparable metrics.
Risk & Volatility
NUS is the less volatile stock with a 1.49 beta — it tends to amplify market swings less than EL's 1.73 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. EL currently trades 70.1% from its 52-week high vs NUS's 48.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | NUSNu Skin Enterpris… | ELThe Estée Lauder … |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.49x | 1.73x |
| 52-Week HighHighest price in past year | $14.62 | $121.64 |
| 52-Week LowLowest price in past year | $5.65 | $57.91 |
| % of 52W HighCurrent price vs 52-week peak | +48.0% | +70.1% |
| RSI (14)Momentum oscillator 0–100 | 46.4 | 66.6 |
| Avg Volume (50D)Average daily shares traded | 458K | 4.6M |
Evenly matched — NUS and EL each lead in 1 of 2 comparable metrics.
Analyst Outlook
NUS leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates NUS as "Hold" and EL as "Hold". Consensus price targets imply 56.7% upside for NUS (target: $11) vs 25.1% for EL (target: $107). For income investors, NUS offers the higher dividend yield at 3.35% vs EL's 2.01%.
| Metric | NUSNu Skin Enterpris… | ELThe Estée Lauder … |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold |
| Price TargetConsensus 12-month target | $11.00 | $106.73 |
| # AnalystsCovering analysts | 11 | 46 |
| Dividend YieldAnnual dividend ÷ price | +3.4% | +2.0% |
| Dividend StreakConsecutive years of raises | 0 | 0 |
| Dividend / ShareAnnual DPS | $0.24 | $1.72 |
| Buyback YieldShare repurchases ÷ mkt cap | +5.8% | +0.1% |
NUS leads this category, winning 1 of 1 comparable metric.
Key Takeaway
NUS leads in 3 of 6 categories (Valuation Metrics, Profitability & Efficiency). EL leads in 2 (Income & Cash Flow, Total Returns). 1 tied.
Best OverallNu Skin Enterprises, Inc. (NUS)Leads 3 of 6 categories
Loading custom metrics...
NUS vs EL: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is NUS or EL a better buy right now?
For growth investors, The Estée Lauder Companies Inc.
(EL) is the stronger pick with -8. 5% revenue growth year-over-year, versus -14. 3% for Nu Skin Enterprises, Inc. (NUS). Nu Skin Enterprises, Inc. (NUS) offers the better valuation at 2. 2x trailing P/E (7. 0x forward), making it the more compelling value choice. Analysts rate Nu Skin Enterprises, Inc. (NUS) a "Hold" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NUS or EL?
On forward P/E, Nu Skin Enterprises, Inc.
is actually cheaper at 7. 0x.
03Which is the better long-term investment — NUS or EL?
Over the past 5 years, The Estée Lauder Companies Inc.
(EL) delivered a total return of -68. 3%, compared to -80. 0% for Nu Skin Enterprises, Inc. (NUS). Over 10 years, the gap is even starker: EL returned +10. 8% versus NUS's -48. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NUS or EL?
By beta (market sensitivity over 5 years), Nu Skin Enterprises, Inc.
(NUS) is the lower-risk stock at 1. 49β versus The Estée Lauder Companies Inc. 's 1. 73β — meaning EL is approximately 16% more volatile than NUS relative to the S&P 500. On balance sheet safety, Nu Skin Enterprises, Inc. (NUS) carries a lower debt/equity ratio of 45% versus 2% for The Estée Lauder Companies Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — NUS or EL?
By revenue growth (latest reported year), The Estée Lauder Companies Inc.
(EL) is pulling ahead at -8. 5% versus -14. 3% for Nu Skin Enterprises, Inc. (NUS). On earnings-per-share growth, the picture is similar: Nu Skin Enterprises, Inc. grew EPS 207. 8% year-over-year, compared to -391. 7% for The Estée Lauder Companies Inc.. Over a 3-year CAGR, EL leads at -7. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NUS or EL?
Nu Skin Enterprises, Inc.
(NUS) is the more profitable company, earning 10. 8% net margin versus -7. 9% for The Estée Lauder Companies Inc. — meaning it keeps 10. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EL leads at 6. 7% versus 6. 1% for NUS. At the gross margin level — before operating expenses — EL leads at 73. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NUS or EL more undervalued right now?
On forward earnings alone, Nu Skin Enterprises, Inc.
(NUS) trades at 7. 0x forward P/E versus 38. 4x for The Estée Lauder Companies Inc. — 31. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NUS: 56. 7% to $11. 00.
08Which pays a better dividend — NUS or EL?
All stocks in this comparison pay dividends.
Nu Skin Enterprises, Inc. (NUS) offers the highest yield at 3. 4%, versus 2. 0% for The Estée Lauder Companies Inc. (EL).
09Is NUS or EL better for a retirement portfolio?
For long-horizon retirement investors, Nu Skin Enterprises, Inc.
(NUS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (3. 4% yield). The Estée Lauder Companies Inc. (EL) carries a higher beta of 1. 73 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NUS: -48. 8%, EL: +10. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NUS and EL?
Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NUS is a small-cap deep-value stock; EL is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(NUS: -16.9% · EL: 4.6%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.